Artivion, Inc. (AORT) stock
Close on Nov 11, 2026Market cap $980.00MP/E –Yield –
Artivion, Inc. grew revenue 14.0% to $481.88M over the twelve months to Sep 30, 2026. Operating income fell 57.1% to $11.05M, moving the operating margin from 6.1% to 2.3%. Free cash flow was -$44.38M, down 353.6% from a year earlier. At the latest close the market valued the company at $980.00M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $980.00M
- P/E ratio
- –
- Price to sales
- 2.03
- Price to book
- 2.20
- Dividend yield
- –
- Free cash flow yield
- -4.53%
Fundamentals
- Revenue
- $481.88M
- Net income
- -$17.59M
- EPS, diluted
- -$0.36
- Free cash flow
- -$44.38M
- Book value per share
- $9.16
- Diluted shares
- 49M
Trading
- Next earnings
- Feb 11, 2027 (estimated, during market hours)
- Previous close
- $20.47
- Open
- $20.25
- Day's range
- $19.82 – $20.73
- Volume
- 646,249
- Average volume (20 days)
- 787,727
- Index membership
- S&P SmallCap 600, Russell 2000, Russell 3000
- Beta (5 years)
- 1.17
- 52-week range
- $19.16 – $48.25
- RSI (14 days)
- 38.3
- Volatility (1 year)
- 54.0%
- Relative volume
- 0.98×
- WACC
- 9.4%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | AORT | S&P 500 | Difference | AORT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -5.5% | -2.4% | −3.0 pts | ||
| 3 months | -29.2% | -1.2% | −28.1 pts | ||
| Year to date | -55.9% | +12.3% | −68.2 pts | ||
| 1 year | -57.1% | +12.4% | −69.6 pts | ||
| 3 years | +50.8% | +78.8% | −28.0 pts | +14.7% | +21.4% |
| 5 years | -3.7% | +75.2% | −78.9 pts | -0.8% | +11.9% |
| 10 years | +6.3% | +311.1% | −304.8 pts | +0.6% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Artivion filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Results
About Artivion
Surgical & Medical Instruments & Apparatus
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues for patients suffering from aortic diseases. The company operates through two primary reportable segments: Medical Devices and Preservation Services. Its medical device offerings include aortic stent grafts, mechanical heart valves, surgical sealants, and related surgical tools. Through its preservation services, the company cryopreserves and supplies human cardiac and vascular donor tissues. Its offerings are primarily used by cardiac and vascular surgeons treating aortic aneurysms, dissections, and heart valve conditions.
Company profile, executives and historyArtivion stock: common questions
What is Artivion's stock price?
AORT closed at $20.10 on Nov 11, 2026, down 1.81% on the day. Over the past 52 weeks it traded between $19.16 and $48.25.
What is Artivion's market cap?
Artivion was worth $980.00M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is AORT's P/E ratio?
Artivion lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.36), so it has no meaningful P/E ratio.
How much revenue does Artivion make?
Artivion reported revenue of $481.88M for the twelve months to Sep 30, 2026, up 14.0% from a year earlier.
Does Artivion pay a dividend?
No. Artivion has not paid a cash dividend over the last twelve months.
When does Artivion report earnings next?
Artivion is expected to report Q4 FY2026 results on Feb 11, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has AORT stock performed over the past year?
Including dividends, AORT returned -57.1% over the past year, against +12.4% for the S&P 500.
How many AORT shares are sold short?
3M shares were sold short at the latest FINRA report, 7.68% of the float, or 7.2 days of average trading volume.
Who are Artivion's competitors?
Companies most similar to Artivion by business, industry and size include LMAT, ATRC, ANGO, BVS, OFIX.
See a number that looks wrong?